BIOAVAILABILITY - MAKING SURE YOU GET MORE OF THE GOOD STUFF!
Bioavailability is the ability of a substance to enter the body’s circulation and so to have an active effect where it is needed.
All Ateronon products have been designed by our science team to be highly bioavailable so that the important ingredients (the ‘good stuff’) can get into your body where they can do good.
The bioavailability of our patented lycopene formulation - LactoLycopene - has proved valuable to independent research centres of excellence too. Ateronon was chosen for clinical studies at Cambridge University and at the prestigious Brigham and Women’s Institute, Boston, USA; under the supervision of a Harvard University professor.
Both studies showed that a daily capsule of Ateronon increased levels of lycopene in the blood, with the Cambridge study showing a 50% increase.
The curcumin (turmeric extract) found in Ateronon Active has been proven to be 30 times more bioavailable than standard turmeric. This has led to the formulation being studied at the Olympic Research Centre in Barcelona. The formula is used by elite athletes and top European football clubs as part of their training regimes.
Ateronon Heart has undergone a series of in-house and independent clinical studies. No other lycopene product has been subject to such in-depth research.
A report containing data on Ateronon was presented at the British Cardiovascular Society conference in June 2014. A copy of the report can be downloaded here.
A Cambridge University study showed Ateronon increased arterial flexibility by 53% and was published in the peer-reviewed science journal PLOSone. The study can be downloaded in full here - http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0099070
An earlier study using Ateronon showed that taking Ateronon had a beneficial effect on cholesterol levels and oxidised LDL. This has since been reviewed by the TGA (Therapeutic Goods Adminstration) in Australia permitting the claim “reduces the oxidation of LDL cholesterol”.
Ateronon XY has been designed to provide the benefits of bioavailable lycopene for men’s health. Numerous studies and media reports have highlighted the benefits lycopene can have on men’s health. A summary can be found on Boots Web MD website - http://search.webmd.boots.com/search/search_results/default.aspx?query=lycopene&sourceType=undefined
A Professor of Surgery and Urology is currently undertaking a study on behalf of CamNutra, investigating the possible links between high lycopene levels in the blood and prostate health and most notably BPH (Benign Prostatic Hyperplasia). Results will be published later this year.
Ateronon Active contains bioavailable curcumin. Curcumin is the key active ingredient of turmeric – a spice well known to provide a range of health benefits. The curcumin in Ateronon Active has been shown to be 30 times more bioavailable than standard forms of curcumin.
A study published in Journal of the International Society of Sports Nutrition in November 2014 found that bioavailable curcumin, incorporated in the unique delivery Meriva® system used in Ateronon Active, has the potential for preventing Delayed Onset Muscle Soreness (DOMS), by reducing the effects of pain intensity and muscle injury.
The DOMS study is to be presented at the Football Medicine Strategies conference in London on April 11th 2015. More details will follow after the event.
The effects of bioavailable curcumin have been scientifically tested with sportsmen and women at the Olympic Research Centre, Barcelona and it is now used by elite sports teams and institutions worldwide.
Medical Advisory board
CamNutra has a Medical Advisory board that directs current and future research projects. Ateronon 4 Life customers also have access to individuals on the advisory board should they wish to ask questions or seek information relating to any Ateronon products. The Medical Advisory Board consists of the following people:
- Prof. Dr. Alf A. Lindberg, M.D, Ph – scientist and former secretary of the Nobel Prize Committee for Physiology and Medicine
- Mr Peter Kirkpatrick, FRCS (SN) FMedSci – Consultant Neurosurgeon, Addenbrooke’s Hospital. Specialist in stroke and cerebral vascular disease.
- Dr Andrew Carson, FRCGP – Medical Director, West Mids Ambulance NHS Trust
- Dr Irina Schurov PhD – CamNutra, Scientific Affairs Manager